
SRY LabsRetatrutide
A severe Jan 2026 identity/quantity failure (0 mg, -100%) is the main concern in SRY Labs' Retatrutide evidence, alongside an early 98.75% purity miss. Later tests resumed passing purity/fill, but batch identifiers are often missing.
We investigated who actually operates SRY Labs — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including SRY Labs rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 8 Jun 2026 | Pass | 49ekutz Tested | lab name | View COA | |||
| 25 Mar 2026 | Pass | 5z6g3k8 Tested | lab name | View COA | |||
| 19 Mar 2026 | Pass | bkqakfa Tested | lab name | View COA | |||
| 2 Mar 2026 | Pass | uetsdhn Tested | lab name | View COA | |||
| 20 Feb 2026 | Pass | ny9s6uu Tested | lab name | View COA | |||
| 15 Feb 2026 | Pass | n72he99 Tested | lab name | View COA | |||
| 29 Jan 2026 | Fail | ace72ek Tested | lab name | View COA | |||
| 25 Nov 2025 | Pass | mfywyaa Tested | lab name | View COA | |||
| 30 Oct 2025 | Pass | nf87fva Tested | lab name | View COA | |||
| 23 Oct 2025 | Pass | 4m99fr5 Tested | lab name | View COA | |||
About SRY Labs test results from Finnrick
SRY Labs is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 121 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible SRY Labs peptides in this dataset are Tirzepatide (35 tests) and Retatrutide (31 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 121 recent tests.